Skip to main content

MoneyWorks4Me

Ganga Pharmaceuticals informs about disclosure

07 Feb 2024 Evaluate
Ganga Pharmaceuticals has informed that it has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Lenus Finvest.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1879.20
Dr. Reddys Labs. 1381.70
Cipla 1402.25
Lupin 2008.70
Zydus Lifesciences 1195.90
View more..